// App-Quantinova.ai

1677 : Assays of conventional chemotherapeutics and targeted drugs for ovarian cancer using patient derived models

Researchers

Presenter

  • Concetta D'Ambrosio

Principal Investigators

  • Maddalena Arigoni

  • Sonia Capellero

  • Gloria Mittica

  • Eleonora Ghisoni

  • Fulvio Borella

  • Dionyssios Katsaros

  • Silvana Privitera

  • Marisa Ribotta

  • Elena Maldi

  • Giovanna Di Nardo

  • Enrico Berrino

  • Tiziana Venesio

  • Riccardo Ponzone

  • Marco Vaira

  • Douglas Hall

  • Mercedes Jimenez-Linan

  • Anna Paterson

  • Giorgio Valabrega

  • Raffaele Calogero

  • James Brenton

  • Mariaflavia Di Renzo

  • Martina Olivero

Medical Centers

  • University of Turin, Candiolo, Italy

  • University of Turin, Turin, Italy

  • A.O.U. Citta della Salute e della Scienza di Torino, Torino, Italy

  • University of Turin, Turin, Italy

  • University of Cambridge, Cambridge, United Kingdom

  • Cancer Research UK - Cambridge Institute, Cambridge, England, United Kingdom

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ovarian cancer

Biomarkers

  • Breast cancer type 1 susceptibility protein

  • Phosphatidylinositol 3-kinase regulatory subunit alpha

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Tumor protein p53

Drug/Treatment

  • Carboplatin

  • buparlisib

  • TP53

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved